Mitumomab

Mitumomab Uses, Dosage, Side Effects, Food Interaction and all others data.

Mitumomab, an anti-BEC-2 monoclonal antibody derived from mice, was previously studied to treat small cell lung carcinoma in combination with BCG vaccination.

Table Of contents

• Mitumomab
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Mitumomab
Generic	Mitumomab
Mitumomab Other Names	BEC2, Mitumomab
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in lung cancer and melanoma.

Innovators Monograph

You find simplified version here Mitumomab